This is the legacy version of We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
Chemjobber Aug 1
Replying to @Davidlaz
Your column: "Harvard’s Frank said that while increased domestic drug production may be prudent from a national security perspective, tapping a company with little pharmaceutical experience as your backstop doesn’t make a lot of sense."